Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed

drug approval expired 99% Health

A phase 2/3 trial of a vaccine candidate against Bundibugyo Ebola has begun enrolling participants in Bunia, Democratic Republic of the Congo. The rollout comes amid an ongoing outbreak and heightened risks for responders, after an attack in Tshopo province killed a nurse and seriously injured another health worker.

🌐 Location: Bunia — Sources: 1 — First seen: — Last seen:
Bundibugyo Ebola vaccine trial Democratic Republic of the Congo Bunia health workers

Linked Entities

Coalition for Epidemic Preparedness Innovations

organization involved

Bunia

location involved 🌐

Tshopo Province

location involved

United Nations

organization involved 🌐

Contributing Articles